Page last updated: 2024-12-08

farnesiferol a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

farnesiferol A: from Ferula szowitsiana; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
FerulagenusA plant genus of the family APIACEAE. It contains pungent oils and resins. It is used to flavor curries, as a carminative, and as cat and dog repellent. The occasionally used common name of 'giant fennel' should not be confused with true fennel (FOENICULUM).[MeSH]ApiaceaeA large plant family in the order Apiales, also known as Umbelliferae. Most are aromatic herbs with alternate, feather-divided leaves that are sheathed at the base. The flowers often form a conspicuous flat-topped umbel. Each small individual flower is usually bisexual, with five sepals, five petals, and an enlarged disk at the base of the style. The fruits are ridged and are composed of two parts that split open at maturity.[MeSH]

Cross-References

ID SourceID
PubMed CID7067262
CHEMBL ID1078138
SCHEMBL ID12362728
MeSH IDM0582916

Synonyms (18)

Synonym
farnesiferol a
CHEMBL1078138
unii-8yc9944mpj
511-33-1
8yc9944mpj ,
2h-1-benzopyran-2-one, 7-(((1s,4as,6r,8ar)-decahydro-6-hydroxy-5,5,8a-trimethyl-2-methylene-1-naphthalenyl)methoxy)-
coumarin, 7-((1,2,3,4,4a.beta.,5,6,7,8,8a-decahydro-6.alpha.-hydroxy-5,5,8a.alpha.-trimethyl-2-methylene-1-naphthyl)methoxy)-
isobadrakemin
2h-1-benzopyran-2-one, 7-((decahydro-6-hydroxy-5,5,8a-trimethyl-2-methylene-1-naphthalenyl)methoxy)-, (1s-(1.alpha.,4a.alpha.,6.beta.,8a.beta.))-
SCHEMBL12362728
DTXSID00199105 ,
farnesiferol a, >=85% (nmr)
ncgc00385155-01!7-[[(1s,4as,6r,8ar)-6-hydroxy-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1h-naphthalen-1-yl]methoxy]chromen-2-one
Q27271205
dtxcid90121596
coumarin, 7-((1,2,3,4,4abeta,5,6,7,8,8a-decahydro-6alpha-hydroxy-5,5,8aalpha-trimethyl-2-methylene-1-naphthyl)methoxy)-
2h-1-benzopyran-2-one, 7-((decahydro-6-hydroxy-5,5,8a-trimethyl-2-methylene-1-naphthalenyl)methoxy)-, (1s-(1alpha,4aalpha,6beta,8abeta))-
AKOS040734812
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID471285Cytotoxicity against human A549 cells after 3 days by MTT assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Influenza A (H(1)N(1)) Antiviral and Cytotoxic Agents from Ferula assa-foetida.
AID471279Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 3 days by XTT assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Influenza A (H(1)N(1)) Antiviral and Cytotoxic Agents from Ferula assa-foetida.
AID471282Cytotoxicity against human MDA-MB-231 cells after 3 days by MTT assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Influenza A (H(1)N(1)) Antiviral and Cytotoxic Agents from Ferula assa-foetida.
AID471283Cytotoxicity against human MCF7 cells after 3 days by MTT assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Influenza A (H(1)N(1)) Antiviral and Cytotoxic Agents from Ferula assa-foetida.
AID471281Cytotoxicity against human HepG2 cells after 3 days by MTT assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Influenza A (H(1)N(1)) Antiviral and Cytotoxic Agents from Ferula assa-foetida.
AID471280Cytotoxicity against human Hep3B cells after 3 days by MTT assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Influenza A (H(1)N(1)) Antiviral and Cytotoxic Agents from Ferula assa-foetida.
AID471284Cytotoxicity against human Ca9-22 cells after 3 days by MTT assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Influenza A (H(1)N(1)) Antiviral and Cytotoxic Agents from Ferula assa-foetida.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]